You can buy or sell Aravive and other stocks, options, and ETFs commission-free!
Aravive, Inc. Common Stock, also called Aravive, is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Read More Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX. The listed name for ARAV is Aravive, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 26, Pre-Market